CONTROLLED SUBSTANCE REPORTING                                                       S.B. 47 (S-4):

                                                                                                    SUMMARY OF BILL

                                                                                      REPORTED FROM COMMITTEE

Senate Bill 47 (Substitute S-4 as reported)

Sponsor:  Senator Dale W. Zorn

Committee:  Health Policy

CONTENT

The bill would amend the Public Health Code to do the following:

-- Delete a provision under which rules promulgated by the Department of Licensing and Regulatory Affairs must exempt from reporting requirements the administration of a controlled substance directly to a patient.

-- Require the rules to exempt from the reporting requirements the dispensing of a controlled substance in a hospital that administers a controlled substance to an inpatient, and, as currently required, the dispensing from a health facility or agency of a controlled substance in a quantity adequate to treat a patient for not more than 48 hours.

-- Provide that the rules would have to require a prescriber to report certain data to the electronic system for monitoring Schedule 2, 3, 4, and 5 controlled substances if the prescriber dispensed buprenorphine, or a drug that contained buprenorphine or methadone, in a substance use disorder program and the patient consented.

-- Rescind an administrative rule that exempts a pharmacist, prescriber, or veterinarian from the reporting requirements in circumstances involving the administration of a controlled substance directly to a patient and the dispensing of a controlled substance in a health facility or agency in a quantity to treat a patient for not more than 48 hours.

The Code requires the Department to establish, by rule, an electronic system for monitoring Schedule 2, 3, 4, and 5 controlled substances dispensed in Michigan by veterinarians, and by pharmacists and dispensing prescribers (physicians and dentists who dispense prescription drugs to their own patients); or dispensed to a Michigan address by a pharmacy licensed in the State.

MCL 333.7333a                                                       Legislative Analyst:  Stephen Jackson

FISCAL IMPACT

The bill would have no fiscal impact on State or local government.

Date Completed:  6-8-17                                                       Fiscal Analyst:  Josh Sefton

This analysis was prepared by nonpartisan Senate staff for use by the Senate in its deliberations and does not constitute an official statement of legislative intent.